Pharma Mar dividend and valuation

PHM · BME · EUR

Compare Pharma Mar
€64.25Change from previous close: −3.53%Absolute change: −€2.35

Close · November 17, 2026

Valuation

Pharma Mar paid €1.00 per share in dividends over the last 12 months (yield 1.6%). Last ex-dividend date: July 8, 2026. The P/E ratio is 16.6. The average price target of 8 analysts is €98.94.

Data as of November 17, 2026

Pharma Mar compared with similar companies

Pharma Mar's P/E (trailing 12 months): 16.6, +34% against the median of a group of 7 similar companies (12.4).

Pharma Mar's metrics compared with similar companies
MetricPharma MarMedian25th–75th percentileBand
P/E (trailing 12 months)16.612.44.60 – 17.3Middle
Forward P/E13.233.416.7 – 52.3Low
EV/EBITDA18.512.94.64 – 15.1High
Price/book4.763.841.74 – 4.76High
Price/sales4.733.642.74 – 11.6Middle
Gross margin93.3%78.3%59.2% – 90.5%High
Operating margin21.3%12.8%-70.7% – 40.8%Middle
Net margin28.8%14.1%0.0% – 44.5%Middle
ROE31.5%19.1%-4.7% – 27.7%High
Debt/equity0.300.050.02 – 0.34Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Pharma Mar: valuation over time

On the latest fiscal year's earnings (2025), Pharma Mar's P/E today is 15.2, in line with the median of its last 5 fiscal years (17.4; between 9.48 and 53.6 from 2020 to 2025). Relative to earnings, it costs about the same as in the past. The dividend yield (1.6%) is above the median of the last 7 fiscal years (1.1%).

Pharma Mar P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/EDividend per shareYield
2025€74.90€4.3017.4€1.001.3%
2024€79.80€1.4953.6€0.801.0%
2023€41.08€0.06—€0.651.6%
2022€64.30€2.7323.6€0.651.0%
2021€57.02€5.1311.1€0.651.1%
2020€71.00€7.499.48€0.600.8%
2019€42.84-€0.50—€0.481.1%
2018€13.08-€0.93———
2017€29.76-€1.54———
2016€32.52-€1.32———

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
€1.12B
Enterprise value
€1.05B
PEG
0.31
EV/revenue
4.42

Profitability and growth

ROA
8.4%
ROIC
39.0%
Revenue growth (year over year)
52.6%

Financial health

Total cash
€176.29M
Total debt
€70.07M
Current ratio
2.36
Quick ratio
1.83
Altman Z-Score
7.29
Piotroski F-Score
5.00

Dividends

Annual dividend per share
€1.00
Dividend yield
1.6%
Payout ratio
25.4%
Ex-dividend date
July 8, 2026

Analysts and estimates

Average price target
€98.94
Median price target
€98.00
High price target
€120.00
Low price target
€80.00
Analysts with a price target
8
Consensus
Buy
Forward EPS
€4.93
EPS estimate, current year
€2.36

Shares and trading

Beta
0.44
Average volume
32.84K
Shares outstanding
17.25M
Float
13.4M
Institutional ownership
11.1%
Insider ownership
21.9%